The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II randomized study of abiraterone acetate plus ADT versus apalutamide versus abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels. (LACOG 0415).
 
Fernando C. Maluf
No Relationships to Disclose
 
Oren Smaletz
No Relationships to Disclose
 
Fabio A. B. Schutz
No Relationships to Disclose
 
Vinicius Carrera Souza
No Relationships to Disclose
 
Andre Poisl Fay
Honoraria - AstraZeneca; Bristol-Myers Squibb; Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis; Pfizer; Roche
 
Daniel Herchenhorn
No Relationships to Disclose
 
Gustavo Werutsky
No Relationships to Disclose
 
Telma Murias Santos
Employment - Janssen